ANTIBODIES AND INTRAVASCULAR CLOTTING IN LIVER CIRRHOSIS
- 1 May 1972
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 299 (7761) , 1181-1182
- https://doi.org/10.1016/s0140-6736(72)91408-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Turnover of 131I-Labelled Fibrinogen in Man: Studies in Normal Subjects, in Congenital Coagulation Factor Deficiency States, in Liver Cirrhosis, in Polycythemia Vera and in Epidermolysis Bullosa1Acta Medica Scandinavica, 2009
- Metabolism of Fibrinogen in Cirrhosis of the LiverJournal of Clinical Investigation, 1971
- The Intestine as a Source of Plasminogen Activator ActivityExperimental Biology and Medicine, 1971
- Significance of the Rate of Decrease in Fibrinogen Level after Total Hepatectomy in DogsAnnals of Surgery, 1966
- Abnormal Plasminogen-Plasmin System Activity (Fibrinolysis) in Patients with Hepatic Cirrhosis: Its Cause and Consequences*Journal of Clinical Investigation, 1964
- Coagulation Disturbances with Manifest Bleeding in Extrahepatic Portal Hypertension and in Liver CirrhosisActa Medica Scandinavica, 1963
- Studies on Spontaneous Fibrinolytic Activity In Patients with Cirrhosis of the Liver and Its Inhibition by Epsilon Amino Caproic AcidAnnals of Surgery, 1961
- Effect of Endotoxin Shock on the Clotting Mechanism of Dogs *Annals of Surgery, 1960
- ALTERATIONS IN THE BLOOD COAGULATION SYSTEM INDUCED BY BACTERIAL ENDOTOXINSThe Journal of Experimental Medicine, 1958
- PLASMA FIBRINOLYTIC ACTIVITY IN CIRRHOSIS OF THE LIVERThe Lancet, 1956